CodeMap® Compliance Briefing: 12/30/2020
For 2021, CMS has chosen to use gap-filling to price an unusually large number of new tests on the Medicare Clinical Laboratory Fee Schedule (CLFS). The final pricing determination includes 53 gap-filled tests, representing 40% of all new tests, including most of the new COVID-19 antigen and antibody tests. Today, we will revisit how gap-filling works and the inherent processes and timelines. As always, please send your questions, comments, and suggestions for future CodeMap® Compliance Briefings to us via email. Happy New Year.
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2020 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.